Browsing by Author "Rodríguez García, Eva"

Sort by: Order: Results:

  • Bloqueo del sistema renina-angiotensina-aldosterona en pacientes con enfermedad renal diabética avanzada
    Bermejo García, Sheila; García, Carles Oriol; Rodríguez García, Eva; Barrios Barrera, Clara; Otero, Sol; Mojal, Sergio; Pascual Santos, Julio; Soler, María José (Elsevier, 2018)
    BACKGROUND AND OBJECTIVES: Diabetic kidney disease is the leading cause of end-stage chronic kidney disease. The renin-angiotensin-aldosterone system (RAAS) blockade has been shown to slow the progression of diabetic kidney ...
  • Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations
    Barrios Barrera, Clara; Otero, Sol; Rodríguez García, Eva; Pedro-Botet, Juan Carlos; Pascual Santos, Julio; Menni, Cristina (Nature Research, 2018)
    Using targeted NMR spectroscopy of 227 fasting serum metabolic traits, we searched for novel metabolic signatures of renal function in 926 type 2 diabetics (T2D) and 4838 non-diabetic individuals from four independent ...
  • Effect of immunosuppressive treatments on kidney outcomes after gross hematuria-related acute kidney injury in older patients with IgA nephropathy
    Sevillano Prieto, Ángel M.; Barrios Barrera, Clara; Rodríguez García, Eva; Spanish Group for the Study of Glomerular Diseases (GLOSEN) (Elsevier, 2023)
    Introduction: Macroscopic hematuria (MH) bouts, frequently accompanied by acute kidney injury (AKI-MH) are one of the most common presentations of IgA nephropathy (IgAN) in the elderly. Immunosuppressive therapies are used ...
  • Extremely high levels of vancomycin can cause severe renal toxicity
    Barceló-Vidal, Jaime; Rodríguez García, Eva; Grau Cerrato, Santiago (Dove Medical Press, 2018)
    Vancomycin has usually been associated with nephrotoxicity. Generally, this toxicity is presented as proximal tubular cells injury with or without necrosis and as acute interstitial nephritis. However, development of both ...
  • Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis.
    Fernandez-Juarez, Gema; Villacorta, Javier; Ruiz-Roso, Gloria; Panizo, Nayara; Martinez-Marín, Isabel; Marco, Helena; Arrizabalaga, Pilar; Díaz, Montserrat; Perez-Gómez, Vanessa; Vaca, Marco; Rodríguez García, Eva; Cobelo, Carmen; Fernandez, Loreto; Avila, Ana; Praga, Manuel; Quereda, Carlos; Ortiz, Alberto (Oxford University Press, 2016)
    BACKGROUND: Variability in the management of glomerulonephritis may negatively impact efficacy and safety. However, there are little/no data on actual variability in the treatment of minimal change disease (MCD)/focal ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking